2022 Oct 17;63(2 Suppl 3):E93-E101
We support and empower our patients with the comprehensive care, resources, and guidance necessary for successful, long-term weight loss
After this initial phase, doses are increased incrementally based on tolerance and treatment goals
Obesity-related HFpEF is the most common phenotype of this disorder 3,9 , and its emergence is causally related to the growing burden of cardiovascularkidneymetabolic disorders observed worldwide 4
Su, Y., Zhao, B., Zhou, L., Zhang, Z., Shen, Y., Lv, H
The addition underscores Ros strategy of positioning itself as a one-stop shop for obesity care, blending telehealth consultations, insurance navigation and pharmacy services